MedTrace Logo

Vitamin D in Minorities With Prediabetes

NCT00876928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2013-06-14

Study results available
· View outcomes & findings →

Summary

Vitamin D supplementation in minority subjects with both pre-diabetes and low vitamin D levels will delay the development of diabetes.

Conditions

  • Pre-diabetes

Interventions

DRUG

vitamin D

liquid vitamin D3 dissolved in medium chain triglyceride once a week

DRUG

placebo

medium chain triglyceride given once per week

Sponsors & Collaborators

Principal Investigators

  • Mayer B. Davidson, MD · Charles Drew University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-01-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00876928 on ClinicalTrials.gov